Ms. Erin Kathleen Bunnell, MA, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 River Rd, Dayton, NV 89403 Phone: 805-714-6200 Fax: 805-268-7013 |
News Archive
Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.
GlaxoSmithKline (GSK) is under Food and Drug Administration (FDA) scrutiny again. This is for its diabetes pill Avandia which is under review for the second time in three years.
The researchers are the first to identify a population of cells with characteristics of adult and embryonic stem cells in cultures derived from biopsies of patients' bone tumors. They describe their findings in the medical journal Neoplasia.
The study by Rowan T. Chlebowski and colleagues at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, involved 2,437 women aged 48 to 79 who were diagnosed with early stage breast cancer and were treated at several medical centers. All the women had the standard treatments such as surgery, radiation therapy, and chemotherapy and or tamoxifen therapy.
An exact determination of expected body weight for adolescents based on age, height and gender is critical for diagnosis and management of eating disorders such as anorexia nervosa and bulimia. However, there are no clear guidelines regarding the appropriate method for calculating this weight in children with such disorders.
› Verified 4 days ago